Peptides DB
Research-centric peptide and protocol reference hub
Study 1 of 17Setmelanotide literatureThe New England journal of medicineTop journal2026

Setmelanotide for the Treatment of Acquired Hypothalamic Obesity.

Not reported in abstract.

Read at The New England journal of medicineAdd to compare

Where it sits

this study against the rest of the setmelanotide corpus
2
Preclinical · this one
11
Observational
0
Open-label
1
Randomised
3
Reviews

Summary and findings

Not reported in abstract.

How much of this paper we could read: title only (0.00). The feed gave us little more than the title, so our summary is thin. This says nothing about the study's quality — read the source. What this means →
2026

Background

Not reported in abstract.

Methods

Not reported in abstract.

Results

Not reported in abstract.

Interpretation

Not reported in abstract.

Limitations

Not reported in abstract.

Elsewhere in the Setmelanotide corpus

BPositioning Incretin-Based and Next-Generation Obesity Management Medications: A Methodological Framework for a Series of Systematic Reviews and Network Meta-Analyses.Diabetes, obesity & metabolism · 2026 · Not reported in abstract.reviewBEffectiveness and Safety of Setmelanotide in a Patient With a Heterozygous PCSK1 Deficiency.Obesity (Silver Spring, Md.) · 2026 · n=1 · 11.8% total weight loss over 3 monthsHumanBGlobal genomics in over 4 million individuals prioritizes therapeutic targets for heart failure and its subtypesbiorxiv-preprint · 2026 · Identified 383 loci associated with heart failure, n=4,468,166.HumanCDiscovery of TL10: A Soluble and Long-Acting MC4R Agonist with Tunable Lipidation for Sustained Pharmacological Activity.Journal of medicinal chemistry · t1/2 ≈ 33.4 h for TL10, a 34-fold increase compared to setmelanotide.AnimalBGoldilocks-Inspired Design of Mid-Size Macrocycles for Selective Targeting of Human Melanocortin Receptors.Journal of medicinal chemistry · Not reported in abstract.HumanCIndustrial-scale production of basil hairy roots in a 1000-L bioreactor and advanced downstream processing for the preparation of cosmetic ingredients.New biotechnology · 2026 · 96.4 kg of biomass fresh weight within 84 days.In vitro